Loading
Immunologist and head of the Institute for Cancer Research at Oslo University Hospital's Norwegian Radium Hospital, leading Norway's largest cancer research institute.
Kjetil Taskén is Head of the Institute for Cancer Research at Oslo University Hospital, The Norwegian Radium Hospital, and a professor at the University of Oslo. His research focuses on signal transduction in immune cells, T cell regulation in the tumour microenvironment, and functional precision medicine through drug sensitivity screening. The institute he leads comprises departments spanning cancer genetics, immunology, molecular oncology, radiation biology and tumour biology.
| Title | Journal | Year |
|---|---|---|
| A national precision cancer medicine implementation initiative for Norway | Nature Medicine | 2022 |
| B cell signalling pathways—New targets for precision medicine in chronic lymphocytic leukaemia | Scandinavian Journal of Immunology | 2020 |
| PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe | Acta Oncologica | 2024 |
Shares Acta oncologica and the tags leadership, clinician-scientist.
Shares Acta oncologica and the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist, immunology.
Shares the tags leadership, clinician-scientist, immunology.
Shares the tags leadership, clinician-scientist, precision oncology.
Shares the tags leadership, clinician-scientist, precision oncology.
Shares the tags leadership, clinician-scientist, immunology.
Shares the tags leadership, clinician-scientist, precision oncology.